(Q35105557)

6 August 2017

1 reference

title

Preventing problems in Ecstasy users: reduce use to reduce harm (English)

1 reference

6 August 2017

Preventing Problems in Ecstasy Users: Reduce Use to Reduce Harm (English)

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

23 December 2023

Matthew J. Baggott

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691205

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12691205

23 December 2023

publication date

1 April 2002

1 reference

full work available at URL

6 August 2017

https://www.tandfonline.com/doi/pdf/10.1080/02791072.2002.10399949

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Journal of Psychoactive Drugs

23 December 2023

published in

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

145-162

1 reference

Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beverage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Substance use among young people: the relationship between perceived functions and intentions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Subjective reports on the effects of the MDMA ('ecstasy') experience in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

The relative contributions of ecstasy and cannabis to cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Pharmacology of MDMA in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Fatal 4-MTA intoxication: development of a liquid chromatographic-tandem mass spectrometric assay for multiple matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Recent paramethoxyamphetamine deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

The effect of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Mood state and brain electric activity in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Identification of the primary gene defect at the cytochrome P450 CYP2D locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

'Weddings, parties, anythingellipsis', a qualitative analysis of ecstasy use in Perth, Western Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Serotonin transporters in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Metabolic consequences of drug misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Low-dose MDMA ("ecstasy") induces vasopressin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Neurovascular deficits in cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Ecstasy (MDMA) dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Gender differences in the subjective effects of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Three cases of fatal paramethoxyamphetamine overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Ambient temperature and mortality from unintentional cocaine overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Hyponatraemia and catatonic stupor after taking "ecstasy".

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Evidence for a possible role for serotonergic systems in the control of cerebral blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Caveat emptor: editors beware

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Dizocilpine and reduced body temperature do not prevent methamphetamine-induced neurotoxicity in the vervet monkey: [11C]WIN 35,428 - positron emission tomography studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Symposium overview: the role of glutathione in neuroprotection and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Memory deficits associated with recreational use of "ecstasy" (MDMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Hippocampal 1H-MRSI in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Patterns of recreational drug use at dance events in Edinburgh, Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Cognitive performance amongst recreational users of "ecstasy".

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Differential effects of Ecstasy and cannabis on self-reports of memory ability: a web-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Is the use of ecstasy and hallucinogens increasing? Results from a community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

MDMA. Nonmedical use and intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

The use of drugs within the techno party scene in European metropolitan cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Cognitive performance and serotonergic function in users of ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults-a transient phenomenon? Results from a longitudinal community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Working memory deficits in current and previous users of MDMA ('ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

"Saturday night fever": ecstasy related problems in a London accident and emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Ecstasy pill testing: harm minimization gone too far?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Interactions of amphetamine analogs with human liver CYP2D6

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2002.10399949

Brain damage and postoperative hyponatremia: the role of gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Chemical analysis of ecstasy pills

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Pharmacokinetic perspectives on megadoses of ascorbic acid

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Memory impairment in abstinent MDMA ("Ecstasy") users

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development.

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Journal of Pharmacology and Experimental Therapeutics

23 December 2023

275

325

Broening H. W.

1995

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Evaluation of serotonergic transporters using PET and [11C](+)McN-5652: assessment of methods

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

5‐HT loss in rat brain following 3, 4‐methylenedioxymethamphetamine (MDMA), p‐chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Substance and alcohol actions/misuse

23 December 2023

105

Davis W. M.

1984

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Fatal uncertainty: death-rate from use of ecstasy or heroin

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Pharmacokinetic model of ascorbic acid in healthy male volunteers during depletion and repletion

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

An unusual case of Ecstasy poisoning

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Toxic effect of MDMA on brain serotonin neurons

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Poisoning with the recreational drug paramethoxyamphetamine ("death").

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy')

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation

23 December 2023

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

23 December 2023

HPLC on the dance floor

101

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Ecstasy--long-term effects on the human central nervous system revealed by positron emission tomography

23 December 2023

109

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits.

23 December 2023

118

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

The residual cognitive effects of heavy marijuana use in college students

23 December 2023

121

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations

23 December 2023

129

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

23 December 2023

Fatal MDMA intoxication

139

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

23 December 2023

140

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT

23 December 2023

142

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine

23 December 2023

143

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Screening experiments of ecstasy street samples using near infrared spectroscopy

23 December 2023

149

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Emergency medical assistance during a mass gathering

23 December 2023

151

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

Ecstasy use in Australia: patterns of use and associated harm

23 December 2023

152

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users

23 December 2023

156

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

23 December 2023

157

1 reference

https://api.crossref.org/works/10.1080/02791072.2002.10399949

23 December 2023

Identifiers

1 reference

6 August 2017

1 reference